Monz takes over as ceo of Carl Zeiss Meditec

Ludwin Monz has been named as chief executive of Carl Zeiss Meditec.

Ludwin Monz has been named as chief executive of Carl Zeiss Meditec. He takes over from Michael Kaschke, who resumes his role as chairman of the company's supervisory board.

Monz has been a member of Carl Zeiss Meditec's management board since October 2007 and is responsible for the firm's Ophthalmological Systems division. Prior to this he led the Microsurgery division for six years.

With a doctorate in physics and an MBA, Monz joined the Carl Zeiss Group in 1994 and has worked in medical technology since 2000.

You may also like

Manufacturing

Breaking down data silos on the plant floor: why MES integration with smart machines matters

The team at DELMIAWorks takes a closer look at how manufacturers can break down data silos on the plant floor by utilising smart machines effectively.
You need to be a subscriber to read this article.
Click here to find out more.
Digital

Designing tomorrow’s medicines with generative AI and quantum computing

As the scale of biological complexity increases, so too must the tools we use to compute it. Pushing beyond the capabilities of classical technology into the realms of generative AI and quantum science, researchers are turning to more advanced techniques to keep up
You need to be a subscriber to read this article.
Click here to find out more.
Digital

The rise of AI-driven IOT

How chemical engineers are helping to strengthen cybersecurity
Regulatory

Accumulus Synergy and Veeva Systems partner to boost life science connectivity

The companies aim to improve the exchange of regulatory data with national regulatory authorities through cloud connectivity
You need to be a subscriber to read this article.
Click here to find out more.
Digital

Closing the AI adoption gap in the life sciences

Martin Stumpe, Chief Data and Artificial Intelligence (AI) Officer at Danaher Corporation, explains how life science innovators can combine cutting-edge AI tools with traditional wet lab processes to improve the molecular design process
Digital

GSK and adesso develop digital solution for reliable adherence to treatment

DREAM reliably reminds patients in 23 countries worldwide to take their medication and attend vaccination appointments
Digital

eschbach wins German innovation award for its Shiftconnector AI suite

Process industry software specialist eschbach has won the prestigious German Innovation Award for its use of artificial intelligence (AI) to drive productivity and efficiency in the chemical and pharmaceutical industries
Subscribe now